Franciszek Kasprzykowski
Franciszek Kasprzykowski
profesor chemii, Wydział Chemii, Uniwersytet Gdański
Verified email at
Cited by
Cited by
Structural studies of cysteine proteases and their inhibitors.
Z Grzonka, E Jankowska, F Kasprzykowski, R Kasprzykowska, ...
Acta Biochimica Polonica 48 (1), 1-20, 2001
Exploration of the conformational space of oxytocin and arginine‐vasopressin using the electrostatically driven Monte Carlo and molecular dynamics methods
A Liwo, A Tempczyk, S Oldziej, MD Shenderovich, VJ Hruby, S Talluri, ...
Biopolymers 38 (2), 157-175, 1996
Structural basis for different inhibitory specificities of human cystatins C and D
A Hall, I Ekiel, RW Mason, F Kasprzykowski, A Grubb, M Abrahamson
Biochemistry 37 (12), 4071-4079, 1998
Synthesis and some pharmacological properties of oxytocin and vasopressin analogs with sarcosine or N-methyl-L-alanine in position 7
Z Grzonka, B Lammek, F Kasprzykowski, D Gazis, IL Schwartz
Journal of medicinal chemistry 26 (4), 555-559, 1983
How non-bonding amino acid side-chains may enormously increase the stability of a Cu (II)—peptide complex
W Bal, M Dyba, F Kasprzykowski, H Kozłowski, R Latajka, L Łankiewicz, ...
Inorganica chimica acta 283 (1), 1-11, 1998
Synthesis of cysteine proteinase inhibitors structurally based on the proteinase interacting N-terminal region of human cystatin C.
A Grubb, M Abrahamson, I Olafsson, J Trojnar, R Kasprzykowska, ...
Biological chemistry Hoppe-Seyler 371, 137-144, 1990
Cystatin C based peptidyl diazomethanes as cysteine proteinase inhibitors: influence of the peptidyl chain length
A Hall, M Abrahamson, A Grubb, J Trojnar, P Kania, R Kasprzykowska, ...
Journal of enzyme inhibition 6 (2), 113-123, 1992
A peptidyl derivative structurally based on the inhibitory center of cystatin C inhibits bone resorption in vitro
L Johansson, A Grubb, M Abrahamson, F Kasprzykowski, ...
Bone 26 (5), 451-459, 2000
Conformational studies of alanine‐rich peptide using CD and FTIR spectroscopy
K bagińska, J Makowska, WŁ Wiczk, F Kasprzykowski, L ChmurzyńSKI
Journal of peptide science: an official publication of the European Peptide …, 2008
Osteoclastogenesis is decreased by cysteine proteinase inhibitors
M Brage, A Lie, M Ransjö, F Kasprzykowski, R Kasprzykowska, ...
Bone 34 (3), 412-424, 2004
Cysteine proteases
Z Grzonka, F Kasprzykowski, WŁ Wiczk
Industrial enzymes, 181-195, 2007
How to find out whether a 5-substituted uracil could be a potential DNA radiosensitizer
L Chomicz, M Zdrowowicz, F Kasprzykowski, J Rak, A Buonaugurio, ...
The Journal of Physical Chemistry Letters 4 (17), 2853-2857, 2013
Synthesis and antibacterial properties of peptidyl derivatives and cyclopeptides structurally based upon the inhibitory centre of human cystatin C: Dissociation of …
F Kasprzykowski, C SchalÉN, R Kasprzykowska, B Jastrzebska, A Grubb
Apmis 108 (7‐8), 473-481, 2000
New antimicrobial cystatin C‐based peptide active against gram‐positive bacterial pathogens, including methicillin‐resistant Staphylococcus aureus and …
A Jasir, F Kasprzykowski, R Kasprzykowska, V Lindström, C Schalen, ...
Apmis 111 (11), 1004-1010, 2003
Cysteine proteinase inhibitors regulate human and mouse osteoclastogenesis by interfering with RANK signaling
F Strålberg, P Henning, I Gjertsson, B Kindlund, PPC Souza, E Persson, ...
The FASEB Journal 27 (7), 2687-2701, 2013
Binding modes of a new epoxysuccinyl–peptide inhibitor of cysteine proteases. Where and how do cysteine proteases express their selectivity?
C Czaplewski, Z Grzonka, M Jaskólski, F Kasprzykowski, M Kozak, ...
Biochimica et Biophysica Acta (BBA)-Protein Structure and Molecular …, 1999
Potential allosteric modulators of the proteasome activity
E Jankowska, M Gaczynska, P Osmulski, E Sikorska, R Rostankowski, ...
Biopolymers 93 (5), 481-495, 2010
Human cysteine cathepsins are not reliable markers of infection by Pseudomonas aeruginosa in cystic fibrosis
C Naudin, A Joulin-Giet, G Couetdic, P Plesiat, A Szymanska, E Gorna, ...
PLoS One 6 (9), 2011
Acyloxymethyl esterification of nodularin-R and microcystin-LA produces inactive protoxins that become reactivated and produce apoptosis inside intact cells
L Herfindal, F Kasprzykowski, F Schwede, L L̷ankiewicz, KE Fladmark, ...
Journal of medicinal chemistry 52 (18), 5758-5762, 2009
Photoaffinity labeling analysis of the interaction of pituitary adenylate‐cyclase‐activating polypeptide (PACAP) with the PACAP type I receptor
YJ Cao, E Kojro, G Gimpl, M Jasionowski, F Kasprzykowski, L Lankiewicz, ...
European journal of biochemistry 244 (2), 400-406, 1997
The system can't perform the operation now. Try again later.
Articles 1–20